Loading...
Loading...
Geron
GERN fell 50.69% to $1.43 at 9:52 am. Geron announced that, on the basis of an unplanned interim analysis, it is discontinuing its randomized Phase 2 study of imetelstat in metastatic HER2-negative breast cancer.
Nordion
NDZ shares dipped 39.06% to $6.49. Nordion announced its plans to suspend its quarterly dividend after an arbitration loss.
Zalicus
ZLCS shares lost 26.62% to $1.02. Zalicus announced top line results from its Phase 2b clinical trial of Synavive® in rheumatoid arthritis.
Synergy Pharmaceuticals
SGYPU dropped 25.52% to $11.15. Synergy Pharmaceuticals' 52-week trading range is $9.80-$15.88.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in